tradingkey.logo

AVITA Medical Inc

RCEL
3.900USD
-0.030-0.76%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
594.62MCap. mercado
PérdidaP/E TTM

AVITA Medical Inc

3.900
-0.030-0.76%

Más Datos de AVITA Medical Inc Compañía

AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.

Información de AVITA Medical Inc

Símbolo de cotizaciónRCEL
Nombre de la empresaAVITA Medical Inc
Fecha de salida a bolsaMar 18, 2012
Director ejecutivoVance (Cary G)
Número de empleados260
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 18
Dirección28159 Avenue Stanford
CiudadVALENCIA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal91355
Teléfono16613679170
Sitio Webhttps://www.avitamedical.com/
Símbolo de cotizaciónRCEL
Fecha de salida a bolsaMar 18, 2012
Director ejecutivoVance (Cary G)

Ejecutivos de AVITA Medical Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
27.71K
--
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
20.61K
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. David O'Toole
Mr. David O'Toole
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jessica Ekeberg
Ms. Jessica Ekeberg
Director - Investor Relations
Director - Investor Relations
--
--
Ms. Nicole Linda Kelsey, J.D.
Ms. Nicole Linda Kelsey, J.D.
Chief Legal and Compliance Officer, Corporate Secretary
Chief Legal and Compliance Officer, Corporate Secretary
--
--
Dr. Michael Tarnoff Tarnoff, M.D.
Dr. Michael Tarnoff Tarnoff, M.D.
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
27.71K
--
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
20.61K
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. David O'Toole
Mr. David O'Toole
Chief Financial Officer
Chief Financial Officer
--
--

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
United States
16.03M
93.96%
Japan
605.00K
3.55%
United Kingdom
345.00K
2.02%
Australia
80.00K
0.47%
European Union (Region)
0.00
0.00%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: jue., 4 de dic
Actualizado: jue., 4 de dic
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
4.74%
BlackRock Institutional Trust Company, N.A.
3.51%
State Street Investment Management (US)
1.39%
Geode Capital Management, L.L.C.
1.09%
Northern Trust Investments, Inc.
0.52%
Otro
88.76%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
4.74%
BlackRock Institutional Trust Company, N.A.
3.51%
State Street Investment Management (US)
1.39%
Geode Capital Management, L.L.C.
1.09%
Northern Trust Investments, Inc.
0.52%
Otro
88.76%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
10.83%
Investment Advisor/Hedge Fund
4.52%
Individual Investor
0.80%
Research Firm
0.74%
Hedge Fund
0.62%
Pension Fund
0.25%
Bank and Trust
0.24%
Venture Capital
0.08%
Otro
81.93%

Participación institucional

Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
207
5.28M
17.31%
-4.20M
2025Q3
206
7.68M
25.17%
-2.00M
2025Q2
210
7.20M
27.22%
-1.82M
2025Q1
225
7.35M
27.79%
-1.89M
2024Q4
218
6.78M
25.72%
-2.16M
2024Q3
215
6.40M
24.41%
-2.52M
2024Q2
210
6.40M
24.65%
-3.74M
2024Q1
216
7.55M
29.29%
-2.27M
2023Q4
213
7.36M
28.65%
-3.81M
2023Q3
208
8.37M
32.77%
-2.77M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
1.37M
4.48%
-84.89K
-5.85%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.07M
3.51%
-668.22K
-38.45%
Sep 30, 2025
State Street Investment Management (US)
423.31K
1.39%
-105.48K
-19.95%
Sep 30, 2025
Geode Capital Management, L.L.C.
331.46K
1.09%
-286.88K
-46.39%
Sep 30, 2025
Northern Trust Investments, Inc.
158.78K
0.52%
-83.25K
-34.40%
Sep 30, 2025
Millennium Management LLC
132.71K
0.44%
-236.48K
-64.05%
Sep 30, 2025
AQR Capital Management, LLC
119.29K
0.39%
+97.36K
+444.12%
Sep 30, 2025
Bridgeway Capital Management, LLC
118.00K
0.39%
+80.40K
+213.84%
Sep 30, 2025
Divisadero Street Capital Management, LP
100.00K
0.33%
+100.00K
--
Sep 30, 2025
HRT Financial LP
93.03K
0.31%
+93.03K
--
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: mar., 2 de dic
Actualizado: mar., 2 de dic
Nombre
Proporción
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
iShares Micro-Cap ETF
0.01%
iShares Core S&P Total U.S. Stock Market ETF
0%
ProShares UltraPro Russell2000
0%
iShares Russell 3000 ETF
0%
Proshares Ultra Russell 2000
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
Direxion Daily S&P Biotech Bull 3X Shares
0%
Ver más
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.02%
iShares Micro-Cap ETF
Proporción0.01%
iShares Core S&P Total U.S. Stock Market ETF
Proporción0%
ProShares UltraPro Russell2000
Proporción0%
iShares Russell 3000 ETF
Proporción0%
Proshares Ultra Russell 2000
Proporción0%
iShares Russell 2000 ETF
Proporción0%
iShares Russell 2000 Growth ETF
Proporción0%
Global X Russell 2000 ETF
Proporción0%
Direxion Daily S&P Biotech Bull 3X Shares
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI